Patent · US Active

BCL-3 inhibitors

US10273218B2 · kind B2 · utility

1Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2015
Grant dateApr 30, 2019
Priority date—
Expiry dateJul 31, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D295/125
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present application relates to compounds of any one of Formulae I, Ia, Ib, Ic, Id, Ie, and If. Compounds of Formula (I) have the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.